Previous 10 | Next 10 |
Emergent BioSolutions Inc. (NYSE: EBS) is one today's most active stocks by volume. So far today, approximately 47.84M shares of Emergent BioSolutions Inc. have been exchanged, as compared to an average 30-day volume of 1.56M shares. Emergent BioSolutions Inc., a life sciences company, focuses...
2024-02-21 08:04:03 ET DENVER, Colo., Feb 21, 2024 (www.247marketnews.com)- Emergent BioSolutions Inc. (NYSE: EBS ) reported, this morning, that Joseph C. Papa was appointed president and CEO, effective today. EBS is trading at $1.71, up $0.19 (+12.50%), on 46K shares traded. It...
2024-02-21 07:13:49 ET More on Emergent Biosolutions Emergent BioSolutions: Q3 Numbers Leave Work To Be Done Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow Emergent BioSolutions extends shelf life of Narcan to 4 years Emergent BioSolutions win...
Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company’s debt GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global company providing solutions that address pu...
2024-01-22 05:00:00 ET Summary After a correction from August through October, the market has been on a tear. Technology had a very good week, especially among the Magnificent 7 mega-cap stocks. The S&P Top 7 stocks continue to dominate the market, but that dominance is sl...
2024-01-17 14:46:11 ET More on Emergent BioSolutions Emergent BioSolutions: Q3 Numbers Leave Work To Be Done Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow Emergent BioSolutions Inc. 2023 Q3 - Results - Earnings Call Presentation Emergent BioS...
2024-01-11 08:18:58 ET More on Emergent Biosolutions Emergent BioSolutions: Q3 Numbers Leave Work To Be Done Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow Emergent BioSolutions Inc. 2023 Q3 - Results - Earnings Call Presentation Emergent Bios...
GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract with a maximum value up to $235.8 million to supply BioThrax ® (Anthrax Vaccine Adsorbed)...
GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich L...
2023-12-18 02:51:34 ET Summary Emergent BioSolutions stock has a call option-like structure to it and trades as an equity stub currently behind a high debt load. However, business performance may be improving into the important Q4 period, with results coming in February 2024. ...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...